These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 3013077

  • 21. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A, Bakogeorgou E, Castanas E.
    Eur J Pharmacol; 1996 Jan 25; 296(2):199-207. PubMed ID: 8838457
    [Abstract] [Full Text] [Related]

  • 22. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ, Green IC, Thorpe JR, Titheradge MA.
    Biochem J; 1990 Apr 01; 267(1):233-40. PubMed ID: 1970240
    [Abstract] [Full Text] [Related]

  • 23. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin.
    Shimohigashi Y, Waki M, Izumiya N, Costa T, Herz A, Kurono M, Yagi K.
    Biochem Int; 1986 Aug 01; 13(2):199-203. PubMed ID: 3021160
    [Abstract] [Full Text] [Related]

  • 24. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B, Gouardères C, Mazarguil H, Audigier Y, Cros J.
    Neuropeptides; 1982 Oct 01; 3(1):53-64. PubMed ID: 6296719
    [Abstract] [Full Text] [Related]

  • 25. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG, Fields HL, Lee NM.
    J Pharmacol Exp Ther; 1986 Sep 01; 238(3):1039-44. PubMed ID: 3018217
    [Abstract] [Full Text] [Related]

  • 26. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA, Lutz RA, Munson PJ, Rodbard D.
    J Pharmacol Exp Ther; 1987 Jul 01; 242(1):15-20. PubMed ID: 3039108
    [Abstract] [Full Text] [Related]

  • 27. Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury.
    Faden AI, Molineaux CJ, Rosenberger JG, Jacobs TP, Cox BM.
    Ann Neurol; 1985 Apr 01; 17(4):386-90. PubMed ID: 2860844
    [Abstract] [Full Text] [Related]

  • 28. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B, Rajpara A, O'Connor LH, Cicero TJ.
    Life Sci; 1988 Apr 01; 42(23):2403-12. PubMed ID: 2836684
    [Abstract] [Full Text] [Related]

  • 29. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.
    J Pharmacol Exp Ther; 1987 May 01; 241(2):393-400. PubMed ID: 3033214
    [Abstract] [Full Text] [Related]

  • 30. Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus.
    Dewar D, Jenner P, Marsden CD.
    Neuroscience; 1985 May 01; 15(1):41-6. PubMed ID: 2989729
    [Abstract] [Full Text] [Related]

  • 31. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD, Leslie JB, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1987 Jan 01; 240(1):150-8. PubMed ID: 3027302
    [Abstract] [Full Text] [Related]

  • 32. Subclass specificity of anti-idiotypic anti-opiate receptor antibodies in rat brain, guinea pig cerebellum, & neuroblastoma x glioma (NG 108-15).
    Myers WE, Glasel JA.
    Life Sci; 1986 May 12; 38(19):1783-8. PubMed ID: 3010023
    [Abstract] [Full Text] [Related]

  • 33. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L, Lee NM.
    J Pharmacol Exp Ther; 1998 Jun 12; 285(3):1181-6. PubMed ID: 9618421
    [Abstract] [Full Text] [Related]

  • 34. Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study.
    Bunn SJ, Hanley MR, Wilkin GP.
    Neurosci Lett; 1985 Apr 19; 55(3):317-23. PubMed ID: 2989733
    [Abstract] [Full Text] [Related]

  • 35. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan 19; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 36. Characterization of opioid binding sites in murine neuroblastoma.
    Zagon IS, Goodman SR, McLaughlin PJ.
    Brain Res; 1988 May 24; 449(1-2):80-8. PubMed ID: 2899449
    [Abstract] [Full Text] [Related]

  • 37. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F, Burks TF.
    J Pharmacol Exp Ther; 1983 Oct 24; 227(1):22-7. PubMed ID: 6312019
    [Abstract] [Full Text] [Related]

  • 38. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec 24; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 39. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF, Goldstein A.
    Mol Pharmacol; 1984 May 24; 25(3):337-42. PubMed ID: 6328259
    [Abstract] [Full Text] [Related]

  • 40. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan 24; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.